Mangrove Partners’s Sotera Health SHC Stock Holding History

Mangrove Partners’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,757	Closed	-$230K	–	194
2024 Q3	$230K	Buy	+13,757	New	+$201K	0.02%	138

Other funds holding SHC

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

DCP

Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

MIG Capital Newport Beach, California $589M AUM 25.96% 1-Year Est. Return

Mangrove Partners's SHC Position: Q4 2024 in Review

Mangrove Partners sold out of Sotera Health (SHC) in Q4 2024, closing a stake of 13,757 shares — an estimated $230K sold.

Mangrove Partners first reported a position in SHC in Q3 2024 and held it in 1 quarter. The position peaked at $230K in Q3 2024. 216 funds tracked by Wall St. Rank hold SHC as of Q4 2024.

Mangrove Partners reported no remaining Sotera Health position as of Q4 2024 after selling out during the quarter.
Mangrove Partners sold 13,757 Sotera Health shares in Q4 2024, an estimated $230K.
Mangrove Partners first reported a position in Sotera Health in Q3 2024 and held it in 1 quarter.
Mangrove Partners's Sotera Health position peaked at $230K in Q3 2024.
216 funds tracked by Wall St. Rank held Sotera Health as of Q4 2024.

Based on Mangrove Partners's 13F filing for Q4 2024, filed 14 Feb 2025.